DaVita
DVA
450 hedge funds and large institutions have $7.55B invested in DaVita in 2018 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 143 increasing their positions, 187 reducing their positions, and 92 closing their positions.
311% more call options, than puts
Call options by funds: $352M | Put options by funds: $85.5M
0.32% more ownership
Funds ownership: 88.47% → 88.79% (+0.32%)
8% less funds holding
Funds holding: 490 → 450 (-40)
24% less repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 187
28% less capital invested
Capital invested by funds: $10.5B → $7.55B (-$2.94B)
40% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 92
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$210M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$167M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$66.8M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$26.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$24.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$203M |
| 2 |
O
OrbiMed
New York
|
-$58.4M |
| 3 |
Renaissance Technologies
New York
|
-$45.5M |
| 4 |
Millennium Management
New York
|
-$39.8M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$33.9M |
DVA Hedge Fund Activity: Q4 2018 in Review
450 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in DaVita (DVA) for Q4 2018, worth a combined $7.55B — down 28% from $10.5B a quarter earlier.
Sellers outnumbered buyers: 92 funds closed out of DVA and 55 opened new positions — a net loss of 37 holders — while 187 trimmed existing stakes and 143 added.
The largest buyer was BlackRock, adding an estimated $210M. The largest seller was OppenheimerFunds, cutting an estimated $203M.
- 450 institutional investors held DaVita (DVA) as of Q4 2018, down from 490 in Q3 2018.
- Funds reported $7.55B of DaVita stock for Q4 2018, down 28% quarter-over-quarter.
- 55 funds opened new DaVita positions in Q4 2018 and 92 closed out, a net change of -37 holders.
- The largest DaVita buyer in Q4 2018 was BlackRock, an estimated $210M added.
- The largest DaVita seller in Q4 2018 was OppenheimerFunds, an estimated $203M sold.
Based on aggregated 13F filings for Q4 2018.